Q3 2013 Holdings
Filed 2013-11-14 | 194 holdings | $1.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2013-11-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals IncCallA | COM | 92532F900 | $188.7K | 24,890 | 12.3% |
| Vertex Pharmaceuticals Inc | COM | 92532F900 | $188.7K | 24,890 | 1.3% |
| Merck & Co IncCallA | COM | 58933Y905 | $82.2K | 17,258 | 5.3% |
| Merck & Co Inc | COM | 58933Y905 | $82.2K | 17,258 | 0.6% |
| Acadia Pharmaceuticals Inc | COM | 004225908 | $82.0K | 29,842 | 0.6% |
| Acadia Pharmaceuticals IncCallA | COM | 004225908 | $82.0K | 29,842 | 5.3% |
| Sarepta Therapeutics IncPutA | COM | 803607950 | $61.5K | 13,028 | 4.0% |
| Sarepta Therapeutics Inc | COM | 803607950 | $61.5K | 13,028 | 0.4% |
| Ishares Msci Japan ETFPutA | ETF | 464286958 | $59.6K | 50,000 | 3.9% |
| Ishares Msci Japan ETF | ETF | 464286958 | $59.6K | 50,000 | 0.4% |
| Gilead Sciences IncPutA | COM | 375558953 | $53.5K | 8,506 | 3.5% |
| Gilead Sciences Inc | COM | 375558953 | $53.5K | 8,506 | 0.4% |
| Vertex Pharmaceuticals Inc | COM | 92532F950 | $49.7K | 6,551 | 0.4% |
| Vertex Pharmaceuticals IncPutA | COM | 92532F950 | $49.7K | 6,551 | 3.2% |
| Ishares 20+ Year Treasury Bond ETF | ETF | 464287902 | $45.2K | 4,250 | 0.3% |
| Ishares 20+ Year Treasury Bond ETFCallA | ETF | 464287902 | $45.2K | 4,250 | 2.9% |
| Spdr S&P 500 ETF Trust Trust Units | UNIT | 78462F953 | $37.8K | 2,250 | 0.3% |
| Spdr S&P 500 ETF Trust Trust UnitsPutA | UNIT | 78462F953 | $37.8K | 2,250 | 2.5% |
| Ishares Russell 2000 ETFPutA | ETF | 464287955 | $37.1K | 3,478 | 2.4% |
| Ishares Russell 2000 ETF | ETF | 464287955 | $37.1K | 3,478 | 0.3% |
| Glaxosmithkline PLC | ADR | 37733W905 | $32.8K | 6,531 | 0.2% |
| Glaxosmithkline PLCCallA | ADR | 37733W905 | $32.8K | 6,531 | 2.1% |
| Regeneron Pharmaceuticals Inc | COM | 75886F907 | $31.3K | 1,001 | 0.2% |
| Regeneron Pharmaceuticals IncCallA | COM | 75886F907 | $31.3K | 1,001 | 2.0% |
| Medivation IncPutA | COM | 58501N951 | $29.5K | 4,918 | 1.9% |
| Medivation Inc | COM | 58501N951 | $29.5K | 4,918 | 0.2% |
| Bristol Myers Squibb CoCallA | COM | 110122908 | $28.4K | 6,139 | 1.8% |
| Bristol Myers Squibb Co | COM | 110122908 | $28.4K | 6,139 | 0.2% |
| Aegerion Pharmaceuticals Inc | COM | 00767E952 | $26.4K | 3,079 | 0.2% |
| Aegerion Pharmaceuticals IncPutA | COM | 00767E952 | $26.4K | 3,079 | 1.7% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $25.5K | 336,955 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $24.7K | 522,041 | 1.6% |
| Ishares 20+ Year Treasury Bond ETF | ETF | 464287952 | $23.9K | 2,250 | 0.2% |
| Ishares 20+ Year Treasury Bond ETFPutA | ETF | 464287952 | $23.9K | 2,250 | 1.6% |
| Allergan IncCallA | COM | 018490902 | $23.0K | 2,540 | 1.5% |
| Allergan Inc | COM | 018490902 | $23.0K | 2,540 | 0.2% |
| Aegerion Pharmaceuticals Inc | COM | 00767E102 | $22.2K | 259,119 | 1.4% |
| Biogen Idec IncCallA | COM | 09062X903 | $21.0K | 874 | 1.4% |
| Biogen Idec Inc | COM | 09062X903 | $21.0K | 874 | 0.2% |
| Mannkind CorpCallA | COM | 56400P901 | $20.0K | 35,130 | 1.3% |
| Mannkind Corp | COM | 56400P901 | $20.0K | 35,130 | 0.1% |
| Aegerion Pharmaceuticals IncCallA | COM | 00767E902 | $18.9K | 2,200 | 1.2% |
| Aegerion Pharmaceuticals Inc | COM | 00767E902 | $18.9K | 2,200 | 0.1% |
| Allergan IncPutA | COM | 018490952 | $18.4K | 2,033 | 1.2% |
| Allergan Inc | COM | 018490952 | $18.4K | 2,033 | 0.1% |
| Celgene CorpPutA | COM | 151020954 | $18.1K | 1,178 | 1.2% |
| Celgene Corp | COM | 151020954 | $18.1K | 1,178 | 0.1% |
| Opko Health Inc | COM | 68375N903 | $16.8K | 19,032 | 0.1% |
| Opko Health IncCallA | COM | 68375N903 | $16.8K | 19,032 | 1.1% |
| Celldex Therapeutics Inc | COM | 15117B903 | $16.2K | 4,582 | 0.1% |